Bayesian inference, predictive coding and delusions

Avant

Volumn 5, Issue 3, 2015, Pages 51-88

  Adams, Rick A ^a   Brown, Harriet R ^a   Friston, Karl J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Active inference; Free energy; Illusions; Precision; Psychosis; Schizophrenia; Sensory attenuation

Indexed keywords

EID: 84928895976     PISSN: None     EISSN: 20826710     Source Type: Journal    
DOI: 10.12849/50302014.0112.0004     Document Type: Article

References (116)

1. Abi-Saab, W., D'Souza, D. C., Moghaddam, B., and Krystal, J. H. 1998. The NMDA Antagonist Model for Schizophrenia: Promise and Pitfalls. Pharmacopsychiatry, 31(2): 104-9. doi: 10.1055/s-2007-979354.
2. Adams, R. A, Perrinet, L. U., and Friston, K. 2012. Smooth Pursuit and Visual Occlusion: Active Inference and Oculomotor Control in Schizophrenia. PloS One, 7(10). e47502. doi: 10.1371/journal.pone.0047502.
3. Adams, R. A., Shipp, S., and Friston, K. 2012. Predictions Not Commands: Active Inference in the Motor System. Brain Structure & Function, 218(3). doi: 10.1007/s00429-012-0475-5.
4. Adams, R. A, Stephan, K. E., Brown, H. R., Frith, C. D., and Friston, K. 2013. The Computational Anatomy of Psychosis. Frontiers in Psychiatry, 4: 47. doi: 10.3389/fpsyt.2013.00047.
5. Albrecht, M. A, Martin-Iverson, M. T., Price, G., Lee, J., Iyyalol, R., and Waters, F. 2011. Dexamphetamine Effects on Separate Constructs in the Rubber Hand Illusion Test. Psychopharmacology, 217(1): 39-50. doi: 10.1007/s00213-011-2255-y.
6. Allen, P., Aleman, A., and McGuire, P. K. 2007. Inner Speech Models of Auditory Verbal Hallucinations: Evidence from Behavioural and Neuroimaging Studies. International Review of Psychiatry (Abingdon, England), 19(4): 407-15. doi: 10.1080/09540260701486498.
7. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4th ed. Washington, DC: Author.
8. Bagal, A., Joseph, A., Kao, P. Y., Tang, C.-M., and Thompson, S. M. 2005. Long-Term Potentiation of Exogenous Glutamate Responses at Single Dendritic Spines. Proceedings of the National Academy of Sciences of the United States of America, 102(40): 14434-39. doi: 10.1073/pnas.0501956102.
9. Ballard, D. H., Hinton, G. E., and Sejnowski, T. J. 1983. Parallel Visual Computation. Nature, 306(5938): 21-26.
10. Bastos, A. M., Usrey, W. M., Adams, R. A., Mangun, G. R., Fries, P., and Friston, K. 2012. Canonical Microcircuits for Predictive Coding. Neuron, 76(4): 695-711. doi: 10.1016/j.neuron.2012.10.038.
11. Blakemore, S. J., Wolpert, D. M., and Frith, C. D. 1998. Central Cancellation of Self-Produced Tickle Sensation. Nature Neuroscience, 1(7): 635-40. doi: 10.1038/2870.
12. Breier, A., Su, T. P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., et al. 1997. Schizophrenia Is Associated with Elevated Amphetamine-Induced Synaptic Dopamine Concentrations: Evidence from a Novel Positron Emission Tomography Method. Proceedings of the National Academy of Sciences of the United States of America, 94(6): 2569-2574.
13. Brown, H., Adams, R. A., Parees, I., Edwards, M., and Friston, K. 2013. Active Inference, Sensory Attenuation and Illusions. Cognitive Processing, 14(4): 411-27. doi: 10.1007/s10339-013-0571-3.
14. Calkins, M. E., Iacono, W. G., Ones, D. S. 2008. Eye Movement Dysfunction in First-Degree Relatives of Patients with Schizophrenia: A Meta-Analytic Evaluation of Candidate Endophenotypes. Brain and Cognition, 68(3): 436-61. doi: 10.1016/j.bandc.2008.09.001.
15. Campion, D., Thibaut, F., Denise, P., Courtin, P., Pottier, M., and Levillain, D. 1992. SPEM Impairment in Drug-Naive Schizophrenic Patients: Evidence for a Trait Marker. Biological Psychiatry, 32(10): 891-902.
16. Cardoso-Leite, P., Mamassian, P., Schütz-Bosbach, S., and Waszak, F. 2010. A New Look at Sensory Attenuation. Action-Effect Anticipation Affects Sensitivity, Not Response Bias. Psychological Science, 21(12): 1740-45. doi: 10.1177/0956797610389187.
17. Carlsson, A., Waters, N., and Carlsson, M. L. 1999. Neurotransmitter Interactions in Schizophrenia-Therapeutic Implications. European Archives of Psychiatry and Clinical Neuroscience 249 Suppl. 4: 37-43.
18. Chawla, D., Lumer, E. D., and Friston, K. 1999. The Relationship between Synchronization among Neuronal Populations and Their Mean Activity Levels. Neural Computation, 11(6): 1389-1411.
19. Corlett, P. R., Honey, G. D., Krystal, J. H., and Fletcher, P. C. 2011. Glutamatergic Model Psychoses: Prediction Error, Learning, and Inference. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 36(1): 294-315. doi: 10.1038/npp.2010.163.
20. Crow, T. J. 1980. Molecular Pathology of Schizophrenia: More than One Disease Process? British Medical Journal, 280(6207): 66-68.
21. Dayan, P., Hinton, G. E., Neal, R. M., and Zemel, R. S. 1995. The Helmholtz Machine. Neural Computation, 7(5): 889-904.
22. Dazzan, P., Morgan, K. D., Chitnis, X., Suckling, J., Morgan, C., Fearon, P., McGuire, P.K., Jones, P. B., Leff, J., and Murray, R. M. 2006. The Structural Brain Correlates of Neurological Soft Signs in Healthy Individuals. Cerebral Cortex (New York, N.Y.: 1991), 16(8): 1225-31. doi: 10.1093/cercor/bhj063.
23. Demjaha, A., Murray, R. M., McGuire, P. K., Kapur, S., and Howes, O. D. 2012. Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia. The American Journal of Psychiatry, 169(11): 1203-10. doi: 10.1176/appi.ajp.2012.12010144.
24. Dima, D., Dietrich, D. E., Dillo, W., and Emrich, H. M. 2010. Impaired Top-down Processes in Schizophrenia: A DCM Study of ERPs. NeuroImage, 52(3): 824-32. doi: 10.1016/j.neuroimage.2009.12.086.
25. Dima, D., Roiser, J. P., Dietrich, D. E., Bonnemann, C., Lanfermann, H., Emrich, H. M., and Dillo, W. 2009. Understanding Why Patients with Schizophrenia Do Not Perceive the Hollow-Mask Illusion Using Dynamic Causal Modelling. NeuroImage, 46(4): 1180-86. doi: 10.1016/j.neuroimage.2009.03.033.
26. Durstewitz, D. 2009. Implications of Synaptic Biophysics for Recurrent Network Dynamics and Active Memory. Neural Networks: The Official Journal of the International Neural Network Society, 22(8): 1189-1200. doi: 10.1016/j.neunet.2009.07.016.
27. Fanous, A., Gardner, C., Walsh, D., and Kendler, K. S. 2001. Relationship between Positive and Negative Symptoms of Schizophrenia and Schizotypal Symptoms in Nonpsychotic Relatives. Archives of General Psychiatry, 58(7): 669-73.
28. Feldman, A. G., and Levin, M. F. 1995. The Origin and Use of Positional Frames of Reference in Motor Control. Behavioral and Brain Sciences, 18(04): 723-44. doi: 10.1017/S0140525X0004070X.
29. Feldman, H., and Friston, K. 2010. Attention, Uncertainty, and Free-Energy. Frontiers in Human Neuroscience, 4: 215. doi: 10.3389/fnhum.2010.00215.
30. Felleman, D. J., and Van Essen, D. C. 1991. Distributed Hierarchical Processing in the Primate Cerebral Cortex. Cerebral Cortex (New York, N.Y.: 1991), 1(1): 1-47.
31. Fleming, S. M., Dolan, R. J., and Frith, C. D. 2012. Metacognition: Computation, Biology and Function. Philosophical Transactions of the Royal Society B: Biological Sciences, 367(1594): 1280-86. doi: 10.1098/rstb.2012.0021.
32. Fletcher, P. C, and Frith, C. D. 2009. Perceiving Is Believing: A Bayesian Approach to Explaining the Positive Symptoms of Schizophrenia. Nature Reviews. Neuroscience, 10(1): 48-58. doi: 10.1038/nrn2536.
33. Frank, M. J. 2005. Dynamic Dopamine Modulation in the Basal Ganglia: A Neurocomputational Account of Cognitive Deficits in Medicated and Nonmedicated Parkinsonism. Journal of Cognitive Neuroscience, 17(1): 51-72. doi: 10.1162/0898929052880093.
34. Freeman, T. P., Morgan, C. J. A., Pepper, F., Howes, O. D., Stone, J. M., and Curran, H. V. 2013. Associative Blocking to Reward-Predicting Cues Is Attenuated in Ketamine Users but Can Be Modulated by Images Associated with Drug Use. Psychopharmacology, 225(1): 41-50. doi: 10.1007/s00213-012-2791-0.
35. Friston, K., Harrison, L., and Penny, W. 2003. Dynamic Causal Modelling. NeuroImage, 19(4): 1273-1302. doi: 10.1016/S1053-8119(03)00202-7.
36. Friston, K. 2009. The Free-Energy Principle: A Rough Guide to the Brain? Trends in Cognitive Sciences, 13(7): 293-301. doi: 10.1016/j.tics.2009.04.005.
37. Friston, K., Daunizeau, J., and Kiebel, S. J. 2009. Reinforcement Learning or Active Inference? PloS One, 4(7): e6421. doi: 10.1371/journal.pone.0006421.
38. Friston, K., Daunizeau, J., Kilner, J., and Kiebel, S. J. 2010. Action and Behavior: A Free-Energy Formulation. Biological Cybernetics, 102(3): 227-60. doi: 10.1007/s00422-010-0364-z.
39. Friston, K., Shiner, T., Fitzgerald, T., Galea, J. M., Adams, R., Brown, H., Dolan, J. R., Moran, R., Stephan, K. E., and Bestmann, S. 2012. Dopamine, Affordance and Active Inference. PLoS Computational Biology, 8(1): e1002327. doi: 10.1371/journal.pcbi.1002327.
40. Friston, K. 2005. Hallucinations and Perceptual Inference. Behav Brain Sci, 28(06): 764-66. doi: 10.1017/S0140525X05290131.
41. Friston, K., and Kiebel, S. 2009. Predictive Coding under the Free-Energy Principle. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 364(1521): 1211-21. doi: 10.1098/rstb.2008.0300.
42. Friston, K., Stephan, K., Li, B., and Daunizeau, J. 2010. Generalised Filtering. Mathematical Problems in Engineering: 1-35. doi: 10.1155/2010/621670.
43. Frith, C., Rees, G., and Friston, K. 1998. Psychosis and the Experience of Self. Brain Systems Underlying Self-Monitoring. Annals of the New York Academy of Sciences, 843: 170-78.
44. Frith, C., and Friston, K. 2012. False Perceptions and False Beliefs: Understanding Schizophrenia. Working Group on Neurosciences and the Human Person: New Perspectives on Human Activities, The Pontifical Academy of Sciences, 8-10 November 2012. Casina Pio IV.
45. Garety, P. A., and Freeman, D . 1999. Cognitive Approaches to Delusions: A Critical Review of Theories and Evidence. The British Journal of Clinical Psychology / the British Psychological Society, 38(Pt 2) (June): 113-54.
46. Ginzburg, V. L. 1955. On the Theory of Superconductivity. Il Nuovo Cimento, 2(6): 1234-50. doi: 10.1007/BF02731579.
47. Goff, D. C., and Coyle, J. T. 2001. The Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia. The American Journal of Psychiatry, 158(9): 1367-77.
48. Goldman-Rakic, P. S., Castner, S. A., Svensson, T. H. Siever, L. J., and Williams, G. V . 2004. Targeting the Dopamine D1 Receptor in Schizophrenia: Insights for Cognitive Dysfunction. Psychopharmacology, 174(1): 3-16. doi: 10.1007/s00213-004-1793-y.
49. Gonzalez-Burgos, G., and Lewis, D. A. 2012. NMDA Receptor Hypofunction, Parvalbumin-Positive Neurons, and Cortical Gamma Oscillations in Schizophrenia. Schizophrenia Bulletin, 38(5): 950-57. doi: 10.1093/schbul/sbs010.
50. Gonzalez-Burgos, G., and Lewis, D. A. 2008. GABA Neurons and the Mechanisms of Network Oscillations: Implications for Understanding Cortical Dysfunction in Schizophrenia. Schizophrenia Bulletin, 34(5): 944-61. doi: 10.1093/schbul/sbn070.
51. Gray, J. A., Feldon, J., Rawlins, J. N. P., Hemsley, D. R., and Smith, A. D. 1991. The Neuropsychology of Schizophrenia. Behavioral and Brain Sciences, 14(01): 1-20. doi: 10.1017/S0140525X00065055.
52. Greenwood, T. A., Light, G. A., Swerdlow, N. R., Radant, A.D., and Braff, D. L. 2012. Association Analysis of 94 Candidate Genes and Schizophrenia-Related Endophenotypes. PLoS ONE, 7(1): e29630. doi: 10.1371/journal.pone.0029630.
53. Gunduz-Bruce, H., Reinhart, R. M. G., Roach, B. J., Gueorguieva, R., Oliver, S., D'Souza, D. C., Ford, J. M., Krystal, J. H., and Mathalon, D. H. 2012. Glutamatergic Modulation of Auditory Information Processing in the Human Brain. Biological Psychiatry, 71(11): 969-77. doi: 10.1016/j.biopsych.2011.09.031.
54. Haken, H. 1983. Synergetics: Introduction and Advanced Topics. 3rd ed. Berlin: Springer.
55. Hall, J., Romaniuk, L., McIntosh, A. M., Steele, J. D., Johnstone, E. C., and Lawrie, S. M. 2009. Associative Learning and the Genetics of Schizophrenia. Trends in Neurosciences, 32(6): 359-65. doi: 10.1016/j.tins.2009.01.011.
56. Harrison, P. J., and Weinberger, D. R. 2005. Schizophrenia Genes, Gene Expression, and Neuropathology: On the Matter of Their Convergence. Molecular Psychiatry, 10(1): 40-68; image 5. doi: 10.1038/sj.mp.4001558.
57. Harrison, P. J., Lewis, D. A., and Kleinman, J. E. 2011. Neuropathology of Schizophrenia. Weinberger D. R., and Harrison, P. J. Schizophrenia, BM, BCh, DM(Oxon) FRCPsych, Wiley-Blackwell: 372-92. http://onlinelibrary.wiley.com/doi/10.1002/9781444327298.ch18/summary.
58. Hinton, G. E., and van Camp, D. 1993. Keeping the Neural Networks Simple by Minimizing the Description Length of the Weights. Proceedings of the Sixth Annual Conference on Computational Learning Theory, 5-13. COLT '93. New York, NY, USA: ACM. doi: 10.1145/168304.168306. http://doi.acm.org/10.1145/168304.168306.
59. Howes, O. D., and Kapur, S . 2009. The Dopamine Hypothesis of Schizophrenia: Version III--the Final Common Pathway. Schizophrenia Bulletin, 35(3): 549-62. doi: 10.1093/schbul/sbp006.
60. Hutton, S. B., Crawford, T. J., Gibbins, H., Cuthbert, I., Barnes, T. R., Kennard, C., and Joyce, E. M. 2001. Short and Long Term Effects of Antipsychotic Medication on Smooth Pursuit Eye Tracking in Schizophrenia. Psychopharmacology, 157(3): 284-91. doi: 10.1007/s002130100803.
61. Hutton, S. B., Crawford, T. J., Puri, B. K., Duncan, L. J., Chapman, M., Kennard, C., Barnes, T. R., and Joyce, E. M. 1998. Smooth Pursuit and Saccadic Abnormalities in First-Episode Schizophrenia. Psychological Medicine, 28(3): 685-92.
62. Jabben, N., Arts, B., van Os, J., and Krabbendam, J. 2010. "Neurocognitive Functioning as Intermediary Phenotype and Predictor of Psychosocial Functioning across the Psychosis Continuum: Studies in Schizophrenia and Bipolar Disorder. The Journal of Clinical Psychiatry, 71(6): 764-74. doi: 10.4088/JCP.08m04837yel.
63. Johnstone, E. C., Owens, D. G., Frith, C. D. and Crow, T. J. 1987. The Relative Stability of Positive and Negative Features in Chronic Schizophrenia. The British Journal of Psychiatry, 150(1): 60-64. doi: 10.1192/bjp.150.1.60.
64. Kantrowitz, J.T., and Javitt, D. C. 2010. N-Methyl-D-Aspartate (NMDA) Receptor Dysfunction or Dysregulation: The Final Common Pathway on the Road to Schizophrenia? Brain Research Bulletin, 83(3-4): 108-21. doi: 10.1016/j.brainresbull.2010.04.006.
65. Kapur, S. 2003. Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia. The American Journal of Psychiatry, 160(1): 13-23.
66. Keane, B. P., Silverstein, S. M., Wang, Y., and Papathomas, T. V. 2013. Reduced Depth Inversion Illusions in Schizophrenia Are State-Specific and Occur for Multiple Ob ject Types and Viewing Conditions. Journal of Abnormal Psychology, 122(2): 506-12. doi: 10.1037/a0032110.
67. Kessler, R. M., Woodward, N. D., Riccardi, P., Li, R., Ansari, M. S., Anderson, S., Dawant, B., Zald, D., and Meltzer, H. Y. 2009. Dopamine D2 Receptor Levels in Striatum, Thalamus, Substantia Nigra, Limbic Regions, and Cortex in Schizophrenic Subjects. Biological Psychiatry, 65(12): 1024-31. doi: 10.1016/j.biopsych.2008.12.029.
68. Kiebel, S., Daunizeau, J., and Friston, K . 2009. Perception and Hierarchical Dynamics. Frontiers in Neuroinformatics, 3: 20. doi: 10.3389/neuro.11.020.2009.
69. Krystal, J. H., Karper, L. P., Seibyl, J. P., Freeman, G. K., Delaney, R., Bremner, J. D., Heninger, G. R., Bowers Jr, M. B., and Charney, D. S. 1994. Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans. Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses. Archives of General Psychiatry, 51(3): 199-214.
70. Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., et al. 1996. Single Photon Emission Computerized Tomography Imaging of Amphetamine-Induced Dopamine Release in Drug-Free Schizophrenic Subjects. Proceedings of the National Academy of Sciences of the United States of America, 93(17): 9235-40.
71. Leung, S., Croft, R. J., Baldeweg, T., and Nathan, P. J. 2007. Acute Dopamine D(1) and D(2) Receptor Stimulation Does Not Modulate Mismatch Negativity (MMN) in Healthy Human Subjects. Psychopharmacology, 194(4): 443-51. doi: 10.1007/s00213-007-0865-1.
72. Liddle, P. F. 1987. The Symptoms of Chronic Schizophrenia. A Re-Examination of the Positive-Negative Dichotomy. The British Journal of Psychiatry: The Journal of Mental Science, 151(August): 145-51.
73. Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., and Grace, A. A. 2008. Circuit-Based Framework for Understanding Neurotransmitter and Risk Gene Interactions in Schizophrenia. Trends in Neurosciences, 31(5): 234-42. doi: 10.1016/j.tins.2008.02.005.
74. Lochner, J. P. A., and Burger, J. F. 1961. Form of the Loudness Function in the Presence of Masking Noise. The Journal of the Acoustical Society of America, 33(12): 1705-7. doi: 10.1121/1.1908548.
75. Luthringer, R., Rinaudo, G., Toussaint, M., Bailey, P., Muller, G., Muzet, A., and Macher, J. 1999. Electroencephalographic Characterization of Brain Dopaminergic Stimulation by Apomorphine in Healthy Volunteers. Neuropsychobiology, 39(1): 49-56. doi: 26560.
76. Maher, B. A. 1974. Delusional Thinking and Perceptual Disorder. Journal of Individual Psychology, 30(1): 98-113.
77. Mockler, D., Riordan, J., and Sharma, T. 1997. Memory and Intellectual Deficits Do Not Decline with Age in Schizophrenia. Schizophrenia Research, 26(1): 1-7. doi: 10.1016/S0920-9964(97)00031-5.
78. Montgomery, J. M., and Madison, D. V. 2004. Discrete Synaptic States Define a Major Mechanism of Synapse Plasticity. Trends in Neurosciences, 27(12): 744-50. doi: 10.1016/j.tins.2004.10.006.
79. Morgan, H. L., Turner, D. C. Corlett, P. R., Absalom, A. R., Adapa, R., Arana, F. S., Pigott, J., et al. 2011. Exploring the Impact of Ketamine on the Experience of Illusory Body Ownership. Biological Psychiatry, 69(1): 35-41. doi: 10.1016/j.biopsych.2010.07.032.
80. Morrison, P. D. 2012. 5: The Search for Madness. Schizophrenia: The Final Frontier-A Festschrift for Robin M. Murray, 71-85. Hove: Psychology Press. http://books.google.co.uk/books?hl=en&lr=&id=A49Fm_9zfBAC&oi=fnd&pg=PA71& ots=fb6brPVa5S&sig=1XnMwcDROLDSEtxuJnhJNBiqqrg.
81. Moutoussis, M., Bentall, R. P., El-Deredy, W., and Dayan, P. 2011. Bayesian Modelling of Jumping-to-Conclusions Bias in Delusional Patients. Cognitive Neuropsychiatry, 16(5): 422-47. doi: 10.1080/13546805.2010.548678.
82. Mumford, D. 1992. On the Computational Architecture of the Neocortex. II. The Role of Cortico-Cortical Loops. Biological Cybernetics, 66(3): 241-51.
83. O'Driscoll, G. A., and Callahan, B. L. 2008. Smooth Pursuit in Schizophrenia: A Meta-Analytic Review of Research since 1993. Brain and Cognition, 68(3): 359-70. doi: 10.1016/j.bandc.2008.08.023.
84. O'Tuathaigh, C. M. P., Salum, C., Young, A. M. J., Pickering, A. D., Joseph, M. H., and Moran, P. M. 2003. The Effect of Amphetamine on Kamin Blocking and Overshadowing. Behavioural Pharmacology, 14(4): 315-22. doi: 10.1097/01.fbp.0000080416.18561.3e.
85. Olney, J. W., and Farber, N. B. 1995. Glutamate Receptor Dysfunction and Schizophrenia. Archives of General Psychiatry, 52(12): 998-1007.
86. Oranje, B., Gispen-de Wied, C. C. , Westenberg H. G. M., Kemner, C. Verbaten, M. N., and Kahn, R. S. 2004. Increasing Dopaminergic Activity: Effects of L-Dopa and Bromocriptine on Human Sensory Gating. Journal of Psychopharmacology (Oxford, England), 18(3): 388-94. doi: 10.1177/026988110401800310.
87. Oranje, B., Gispen-de Wied, C. C., Verbaten, M. N., and Kahn, R. S. 2002. Modulating Sensory Gating in Healthy Volunteers: The Effects of Ketamine and Haloperidol. Biological Psychiatry, 52(9): 887-95.
88. Passafaro, M., Piëch, V., and Sheng, M. 2001. Subunit-Specific Temporal and Spatial Patterns of AMPA Receptor Exocytosis in Hippocampal Neurons. Nature Neuroscience, 4(9): 917-26. doi: 10.1038/nn0901-917.
89. Passie, T., Karst M., Borsutzky, M., Wiese, B., Emrich, H. M., and Schneider, U. 2003. Effects of Different Subanaesthetic Doses of (S)-Ketamine on Psychopathology and Binocular Depth Inversion in Man. Journal of Psychopharmacology (Oxford, England), 17(1): 51-56.
90. Phillips, W. A., and Silverstein, S. M. 2003. Convergence of Biological and Psychological Perspectives on Cognitive Coordination in Schizophrenia. The Behavioral and Brain Sciences, 26(1): 65-82; discussion 82-137.
91. Radant, A. D., Bowdle, T. A., Cowley, D. S., Kharasch, E. D., and Roy-Byrne, P. P. 1998. Does Ketamine-Mediated N-Methyl-D-Aspartate Receptor Antagonism Cause Schizophrenia-like Oculomotor Abnormalities? Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 19(5): 434-44. doi: 10.1016/S0893-133X(98)00030-X.
92. Rao, R. P., and Ballard, D. H. 1999. Predictive Coding in the Visual Cortex: A Functional Interpretation of Some Extra-Classical Receptive-Field Effects. Nature Neuroscience, 2(1): 79-87. doi: 10.1038/4580.
93. Razoux, F., Garcia, R., and Léna, I. 2007. Ketamine, at a Dose That Disrupts Motor Behavior and Latent Inhibition, Enhances Prefrontal Cortex Synaptic Efficacy and Glutamate Release in the Nucleus Accumbens. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 32(3): 719-27. doi: 10.1038/sj.npp.1301057.
94. Reilly, J. L., Lencer, R., Bishop, J. R., Keedy, S., and Sweeney, J. A. 2008. Pharmacological Treatment Effects on Eye Movement Control. Brain and Cognition, 68(3): 415-35. doi: 10.1016/j.bandc.2008.08.026.
95. Reith, J., Benkelfat, C., Sherwin, A., Yasuhara, Y., Kuwabara., H., Andermann, F., Bachneff, S., et al. 1994. Elevated Dopa Decarboxylase Activity in Living Brain of Patients with Psychosis. Proceedings of the National Academy of Sciences of the United States of America, 91(24): 11651-54.
96. Richards, A. M. 1968. Monaural Loudness Functions under Masking. The Journal of the Acoustical Society of America, 44(2): 599-605.
97. Salinas, E., and Their, P. 2000. Gain Modulation: A Major Computational Principle of the Central Nervous System. Neuron, 27(1): 15-21.
98. Schmidt, A., Bachmann, R., Kometer, M., Csomor, P. A, Stephan, K. E., Seifritz, E, and Vollenweider, F. X. 2012. Mismatch Negativity Encoding of Prediction Errors Predicts S-Ketamine-Induced Cognitive Impairments. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 37(4): 865-75. doi: 10.1038/npp.2011.261.
99. Shergill, S. S., Bays, P. M., Frith, C. D., and Wolpert, D. M. 2003. Two Eyes for an Eye: The Neuroscience of Force Escalation. Science (New York, N.Y.), 301(5630): 187. doi: 10.1126/science.1085327.
100. Shergill, S. S., Samson, G., Bays, P. M., Frith, C. D, and Wolpert, D. M. 2005. Evidence for Sensory Prediction Deficits in Schizophrenia. The American Journal of Psychiatry, 162(12): 2384-86. doi: 10.1176/appi.ajp.162.12.2384.
101. Shi, W.-X., and Zhang, X.-X. 2003. Dendritic Glutamate-Induced Bursting in the Prefrontal Cortex: Further Characterization and Effects of Phencyclidine. The Journal of Pharmacology and Experimental Therapeutics, 305(2): 680-87. doi: 10.1124/jpet.102.046359.
102. Silverstein, S. M., and Keane, B. P. 2011. Perceptual Organization Impairment in Schizophrenia and Associated Brain Mechanisms: Review of Research from 2005 to 2010. Schizophrenia Bulletin, 37(4): 690-99. doi: 10.1093/schbul/sbr052.
103. Simpson, E. H., Kellendonk, C., and Kandel, E. 2010. A Possible Role for the Striatum in the Pathogenesis of the Cognitive Symptoms of Schizophrenia. Neuron, 65(5): 585-96. doi: 10.1016/j.neuron.2010.02.014.
104. Speechley, W. J., Whitman, J. C., and Woodward, T. S. 2010. The Contribution of Hypersalience to the 'Jumping to Conclusions' Bias Associated with Delusions in Schizophrenia. Journal of Psychiatry & Neuroscience: JPN, 35(1): 7-17.
105. Stephan, K. E., Baldeweg T., and Friston, K. 2006. Synaptic Plasticity and Dysconnection in Schizophrenia. Biological Psychiatry, 59(10): 929-39. doi: 10.1016/j.biopsych.2005.10.005.
106. Stephan, K. E., Friston, K., and Frith, C. D. 2009. Dysconnection in Schizophrenia: From Abnormal Synaptic Plasticity to Failures of Self-Monitoring. Schizophrenia Bulletin, 35(3): 509-27. doi: 10.1093/schbul/sbn176.
107. Stone, J. M., Erlandsson, K., Arstad, E., Squassante, L., Teneggi, V. Bressan, R. A., Krystal, J. H., Ell, P. J., and Pilowsky, L. S. 2008. Relationship between Ketamine-Induced Psychotic Symptoms and NMDA Receptor Occupancy: A [(123)I]CNS-1261 SPET Study. Psychopharmacology. 197(3): 401-8. doi: 10.1007/s00213-007-1047-x.
108. Sweeney, J. A., Haas, G. L., Li, S., and Weiden, P. J. 1994. Selective Effects of Antipsychotic Medications on Eye-Tracking Performance in Schizophrenia. Psychiatry Research, 54(2): 185-98.
109. Teufel, C., Kingdon, A., Ingram, J. N., Wolpert, D. M., and Fletcher, P. C. 2010. Deficits in Sensory Prediction Are Related to Delusional Ideation in Healthy Individuals. Neuropsychologia, 48(14): 4169-72. doi: 10.1016/j.neuropsychologia.2010.10.024.
110. Uhlhaas, P. J, Millard, I., Muetzelfeldt, Curran, H. V., and Morgan, C. J. A. 2007. Perceptual Organization in Ketamine Users: Preliminary Evidence of Deficits on Night of Drug Use but Not 3 Days Later. Journal of Psychopharmacology (Oxford, England), 21(3): 347-52. doi: 10.1177/0269881107077739.
111. Umbricht, D., Schmid, L., Koller, R., Vollenweider, F. X., Hell, D., and Javitt, D. C . 2000. Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers: Implications for Models of Cognitive Deficits in Schizophrenia. Archives of General Psychiatry, 57(12): 1139-47.
112. Weiler, M. A., Thaker, G. K., Lahti, A. C., and Tamminga, C. A. 2000. Ketamine Effects on Eye Movements. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 23(6): 645-53. doi: 10.1016/S0893-133X(00)00156-1.
113. Williams, L. E., Ramachandran, V. S., Hubbard, E. M., Braff, D. L, and Light, G. A. 2010. Superior Size-Weight Illusion Performance in Patients with Schizophrenia: Evidence for Deficits in Forward Models. Schizophrenia Research, 121(1-3): 101-6. doi: 10.1016/j.schres.2009.10.021.
114. Winterer, G., and McCarley, R. W. 2011. Electrophysiology of Schizophrenia. Weinberger, D. R., and Harrison, P. J. Schizophrenia, (3rd ed.): 311-33. Oxford: Wiley-Blackwell. http://onlinelibrary.wiley.com/doi/10.1002/9781444327298.ch15/summary.
115. World Health Organization. 1992. ICD-10: International Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO.
116. Young, A. M. J., Moran, P. M., and Joseph, M. H. 2005. The Role of Dopamine in Conditioning and Latent Inhibition: What, When, Where and How? Neuroscience and Biobehavioral Reviews, 29(6): 963-76. doi: 10.1016/j.neubiorev.2005.02.004.